Darcy Bachert, CEO of Prolucid Technologies expects the Optiscan telepathology platform to revolutionise patient care by bringing the pathology lab straight to the bedside, ensuring real-time diagnostics and swift, life-saving decisions.
- Forums
- ASX - By Stock
- OIL
- Ann: Optiscan Completes Cloud-based Telepathology Software MVP
OIL
optiscan imaging limited
Add to My Watchlist
0.00%
!
10.0¢

Ann: Optiscan Completes Cloud-based Telepathology Software MVP, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.53M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 174885 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 2352 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 174885 | 0.100 |
2 | 51000 | 0.095 |
1 | 200000 | 0.080 |
1 | 7500 | 0.075 |
1 | 60000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 2352 | 1 |
0.115 | 143000 | 2 |
0.120 | 91660 | 3 |
0.130 | 88034 | 3 |
0.135 | 20000 | 1 |
Last trade - 08.43am 30/06/2025 (20 minute delay) ? |
Featured News
OIL (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online